about
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes studyPI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.A retrospective study of late adverse events in proton beam therapy for prostate cancer.Synergistic Effects of NDRG2 Overexpression and Radiotherapy on Cell Death of Human Prostate LNCaP CellsQuality of life in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: results from a prospective longitudinal study.
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
External beam radiation therapy for prostate cancer.
@ast
External beam radiation therapy for prostate cancer.
@en
External beam radiation therapy for prostate cancer.
@nl
type
label
External beam radiation therapy for prostate cancer.
@ast
External beam radiation therapy for prostate cancer.
@en
External beam radiation therapy for prostate cancer.
@nl
prefLabel
External beam radiation therapy for prostate cancer.
@ast
External beam radiation therapy for prostate cancer.
@en
External beam radiation therapy for prostate cancer.
@nl
P1433
P1476
External beam radiation therapy for prostate cancer.
@en
P2093
P304
349-75; quiz 376-9
P356
10.3322/CANJCLIN.50.6.349
P407
P577
2000-11-01T00:00:00Z